Vector BioPharma
Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.
2
Funding Rounds
$60.0m
Money raised
Overview
Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.
-
Website:
- Business model: B2B
- Headquarters: Basel
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Lo**** Ma** | - | - |
Funding series
Funding Series Analysis
The company Vector BioPharma has raised a total of $60m in funding over 2 rounds.
Key Insights:
- Vector BioPharma Series A round, August 10, 2022: $30m
- Vector BioPharma August 2022 Series A Funding Round: $30m
Vector BioPharma Series A round, August 10, 2022
$30m
Vector BioPharma August 2022 Series A Funding Round
$30m
Industries
Vector BioPharma is active in the following industries: